BSc (Hons), University of St Andrews, Scotland
Master of Science, Instrumentation, University of Manchester
Postgrad Certificate in Science Media & Journalism, University of Technology, Sydney

Andy is the Managing Director, Life Sciences at Talu Ventures. He was one of the three founders of Talu Ventures which was established as the successor to CM Capital. Andy joined CM Capital in August 2003 and assumed the role of head of the Life Sciences Practice at CM in 2006. Prior to his venture investment roles, Andy has 15 years of experience in biomedical R&D project management, marketing and business development. His primary expertise is in the commercialisation and globalisation of technology based products and brings to Talu an extensive network of industry contacts within the biotechnology, high technology and pharmaceutical industries. Andy has active board roles across the CMVT4 Life Sciences portfolio and adds to those companies the benefit of his international experience in business development, contractual negotiation, strategic relationship building and licensing.

Within Andy’s professional career he spent 5 years at AGEN, where he was responsible for the management of the company’s instrumentation and biosensor program and latterly for the primary business planning and management of the Thromboview Project. More recently he spent 4 years at Lake Technology as Director of Business Development & Licensing, where he was instrumental in the worldwide business development and marketing of Dolby Headphone™ and Dolby Virtual Speaker™ technologies which have since been adopted by leading brand consumer electronics companies, airlines and PC companies.